期刊文献+

酒精性肝硬化与Hp感染相关性的Meta分析 被引量:3

Alcoholic cirrhosis and Hp infection in Meta-analysis
下载PDF
导出
摘要 目的:探讨酒精性肝硬化与幽门螺旋杆菌(Helicobacter pylori ,Hp )感染的相关性。方法收集已发表的酒精性肝硬化患者感染 Hp 发病率的文献,记录发表年份、地区、第一作者、研究人群及检测方法等,建立 Meta 回归模型并同时进行亚组分析及异质性检测。结果共搜索318篇文献,8篇符合入选标准。入选文献共纳入人数14226名,总的 Hp 感染率为70.67%。Meta 分析结果揭示酒精性肝硬化患者及对照组之间 Hp 感染率无明显差异(OR =0.82,95%CI :0.35~1.91,P <0.01)。亚组分析提示欧洲人群中酒精性肝硬化患者的 Hp 感染率明显高于对照组,而亚洲人群则无明显差异。结论欧洲人群中酒精性肝硬化患者的 Hp 感染率明显高于对照组。 Objective To quantify the association between alcoholic cirrhosis and H .Pylori infection.Methods Published information on H .Pylori prevalence in patients with alcoholic cirrhosis was collected to assess the potential associations between H .Pylori infection and alcoholic cirrhosis risk.Eligible studies were included for analysis.Data on the publication year,detection methods and study populations were summarized.Meta-regression models and subgroup analyses were established to screen the factors resulting heterogeneity.Results Among the 318 articles retrieved,8 met the inclusion criteria.These studies involved 14226 cases,with a total H .Pylori infection rate of 70.67%.This meta-analysis showed no significantly difference in H .Pylori infection rate between the patients with alcoholic cirrhosis and the controls (OR)=0.82,95% CI :0.35~1 .91 ,P 〈0.0001).Subgroup analysis revealed that unlike Asian,European subjects demonstrated a significantly higher prevalence of the H .Pylori infection in the patients with alcoholic cirrhosis. Conclusion The pooled data suggest that alcoholic cirrhosis is significantly associated with higher H .Pylori infection rate in Europe.Large-scale and multicenter studies are needed for further investigation on the relation between alcoholic cirrhosis and H.Pylori infection.
出处 《肝脏》 2014年第12期930-933,共4页 Chinese Hepatology
关键词 幽门螺旋杆菌 酒精性肝硬化 META 分析 Helicobacter pylori Alcoholic cirrhosis Meta-analysis
  • 相关文献

参考文献26

  • 1Bruix J, Sherman M. American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology, 2011, 53 :1020-1022.
  • 2E1-Serag HB. Hepatocellular carcinoma. N Engl J Med, 2011, 365 : 1118-1127.
  • 3Lo GH, Yu HC, Chan YC, et al. The effects of eradication of Helicobacter pylori on the recurrence of duodenal ulcers in patients with cirrhosis. Gastrointest Endosc, 2005, 62:350-356.
  • 4Trinehieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol, 2012, 30:677-706.
  • 5Pellicano R, Manard A, Rizzetto M, et al. Helicobaeter species and liver diseases: association or causation? Lancet Infect Dis, 2008, 8 : 254-260.
  • 6Pellicano R, Fagoonee S, Rizzetto M, et al. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol, 2003, 29: 351-359.
  • 7Butterworth, R. F. Hepatic encephalopathy. Alcohol Res Health, 2003, 27 : 240-246.
  • 8DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials, 1986, 7 : 177-188.
  • 9Harbord RM, Egger M, Sterne JA.. A modified test for small- study effects in meta-analyses of controlled trials with binary endpoints. Stat Med, 2006, 25:3443-3457.
  • 10Everhart JE, Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am, 2000, 29:559- 578.

同被引文献32

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部